Crainio Non-invasive ICP Monitor for TBI
Recruiting
N/A
Interventional Study
Traumatic Brain Injury
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 16 – 99
- Sex
- Any
- Study type
- Interventional
- Purpose
- Diagnostic
- Participants needed
- 54 (estimated)
- Sponsor
- Crainio Ltda · Industry
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The clinical investigation aims to advance the Crainio device, designed for non-invasive intracranial pressure (ICP) monitoring. This feasibility study involves 54 participants over a 12-month period and seeks to collect cerebral photoplethysmogram signals alongside concurrent invasive ICP measurements in patients with traumatic brain injury. The primary objective is to establish the diagnostic ac…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Clinical diagnosis of traumatic brain injury.
* Adults (aged between 16 and 99, male and female)
* TBI patients admitted to the Royal London Hospital.
* Patients having invasive ICP monitoring as part of their normal medical treatment.
Exclusion Criteria:
* Forehead skin is …
Contacts